Management of Patients with Brain Metastases Receiving Trastuzumab Treatment for Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 2296-5262|34|6|304-308

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.34, Iss.6, 2011-05, pp. : 304-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prolonged Survival of Patients Receiving Trastuzumab beyond Disease Progression for HER2 Overexpressing Metastatic Breast Cancer (MBC)

By  

Oncology Research and Treatment, Vol. 28, Iss. 11, 2005-10 ,pp. : 582-586

Karger

Access to resources Recommend Favorite

Trastuzumab Combined with Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer

By  

Oncology, Vol. 76, Iss. 4, 2009-03 ,pp. : 275-285

Karger

Access to resources Recommend Favorite

Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer

By Sherrill Beth   Di Leo Angelo   Amonkar Mayur M.   Wu Yun   Zvirbule Zanete   Aziz Zeba   Bines Jose   Gomez Henry L.  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 767-775

Informa Healthcare

Access to resources Recommend Favorite

Topotecan Chemotherapy in Patients with Breast Cancer and Brain Metastases: Results of a Pilot Study

By  

Oncology Research and Treatment, Vol. 24, Iss. 3, 2001-07 ,pp. : 256-260

Karger

Access to resources Recommend Favorite

Clinical Outcomes and Breast Cancer Subtypes in Patients with Brain Metastases

By  

Oncology Research and Treatment, Vol. 33, Iss. 4, 2010-03 ,pp. : 146-152

Karger

Access to resources Recommend Favorite